https://ir.neogenomics.com/ https://ir.neogenomics.com/news-events https://ir.neogenomics.com/news-events/press-releases https://ir.neogenomics.com/news-events/ir-calendar https://ir.neogenomics.com/news-events/presentations https://ir.neogenomics.com/news-events/email-alerts https://ir.neogenomics.com/company-information https://ir.neogenomics.com/company-information/executive-team https://ir.neogenomics.com/company-information/faq https://ir.neogenomics.com/financial-information https://ir.neogenomics.com/financial-information/financial-results https://ir.neogenomics.com/financial-information/income-statement https://ir.neogenomics.com/financial-information/balance-sheet https://ir.neogenomics.com/financial-information/cash-flow https://ir.neogenomics.com/stock-info/quote https://ir.neogenomics.com/stock-info/chart https://ir.neogenomics.com/stock-info/historical-data https://ir.neogenomics.com/stock-info/analyst-coverage https://ir.neogenomics.com/sec-filings https://ir.neogenomics.com/sec-filings/all-sec-filings https://ir.neogenomics.com/sec-filings/annual-reports https://ir.neogenomics.com/sec-filings/quarterly-reports https://ir.neogenomics.com/sec-filings/section-16-filings https://ir.neogenomics.com/corporate-governance https://ir.neogenomics.com/corporate-governance/board-of-directors https://ir.neogenomics.com/corporate-governance/board-committees https://ir.neogenomics.com/corporate-governance/governance-documents https://ir.neogenomics.com/news-events/press-releases/detail/323/neogenomics-pantracer-lbx-receives-medicare-coverage-expanding-access-to-comprehensive-liquid-biopsy-profiling 2026-03-16T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/322/neogenomics-launches-radar-st-expanding-molecular-residual-disease-testing-across-multiple-solid-tumor-types 2026-02-25T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/321/neogenomics-to-participate-in-upcoming-investor-conferences 2026-02-18T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/320/neogenomics-reports-fourth-quarter-and-full-year-2025-results 2026-02-17T07:05:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/319/neogenomics-introduces-pantracer-pro-to-support-timely-informed-solid-tumor-therapy-selection 2026-02-12T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/318/neogenomics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-17-2026 2026-01-27T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/317/neogenomics-announces-preliminary-fourth-quarter-and-full-year-2025-revenue 2026-01-12T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/316/neogenomics-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference 2026-01-05T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/315/neogenomics-appoints-diagnostics-and-lab-services-industry-veteran-john-p-jack-kenny-to-its-board-of-directors 2025-12-30T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/314/neogenomics-announces-that-natera-has-voluntarily-withdrawn-its-appeal-in-ongoing-radar-patent-litigation 2025-12-15T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/313/neogenomics-to-present-new-ctdna-research-at-sabcs-2025 2025-12-10T07:05:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/312/neogenomics-to-present-real-world-study-on-comprehensive-genomic-profiling-in-myeloid-malignancies-at-ash-2025 2025-12-08T08:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/311/neogenomics-to-participate-in-upcoming-investor-conferences 2025-11-06T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/310/neogenomics-to-present-radar-st-bridging-study-at-islb-2025-demonstrating-reliable-mrd-detection-across-solid-tumors 2025-10-30T12:51:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/309/neogenomics-reports-third-quarter-2025-results 2025-10-28T07:05:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/308/neogenomics-to-highlight-radar-st-mrd-assay-at-esmo-congress-2025 2025-10-14T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/307/neogenomics-to-report-third-quarter-2025-financial-results-on-october-28-2025 2025-10-07T07:05:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/306/court-rules-for-neogenomics-in-patent-infringement-lawsuit-against-natera 2025-08-29T07:05:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/305/neogenomics-launches-pantracer-lbx-expanding-access-to-comprehensive-genomic-profiling-with-liquid-biopsy 2025-07-30T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/304/neogenomics-reports-second-quarter-2025-results 2025-07-29T07:05:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/303/neogenomics-to-report-second-quarter-2025-financial-results-on-july-29-2025 2025-07-01T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/302/neogenomics-announces-pantracer-tissue-and-pantracer-tissue-hrd-now-available-to-support-more-informed-and-timely-cancer-care 2025-06-30T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/301/neogenomics-appoints-dr-marjorie-green-to-board-of-directors 2025-06-24T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/300/neogenomics-debuts-pantracer-family-of-genomic-profiling-tests-at-asco-2025 2025-05-28T07:10:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/299/neogenomics-launches-c-met-cdx-assay-to-guide-treatment-decisions-for-advanced-non-small-cell-lung-cancer 2025-05-22T07:10:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/298/neogenomics-to-participate-in-upcoming-june-investor-conferences 2025-05-20T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/297/neogenomics-pays-off-1-25-convertible-senior-notes 2025-05-01T07:05:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/296/neogenomics-reports-first-quarter-2025-results 2025-04-29T07:30:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/295/neogenomics-to-showcase-pantracer-lbx-validation-study-at-aacr-annual-meeting 2025-04-22T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/294/neogenomics-to-report-first-quarter-2025-financial-results-on-april-29-2025 2025-04-08T07:05:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/293/neogenomics-completes-acquisition-of-pathline 2025-04-07T07:05:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/292/tony-zook-assumes-role-as-chief-executive-officer-of-neogenomics 2025-04-01T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/291/neogenomics-appoints-warren-stone-as-president-chief-operating-officer 2025-03-18T07:05:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/290/neogenomics-expands-oncology-testing-reach-in-the-northeast-with-acquisition-of-pathline 2025-03-10T07:00:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/289/neogenomics-to-participate-in-upcoming-investor-conferences 2025-02-24T07:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/288/neogenomics-reports-fourth-quarter-and-full-year-2024-results 2025-02-18T07:05:03-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/287/neogenomics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-18-2025 2025-01-29T08:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/286/neogenomics-provides-2025-financial-guidance-and-updates-long-range-financial-plan 2025-01-15T07:05:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/285/adaptive-biotechnologies-and-neogenomics-partner-to-expand-access-to-personalized-disease-monitoring-for-blood-cancer-patients 2025-01-14T12:58:27-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/284/neogenomics-announces-chief-executive-officer-succession 2025-01-10T07:05:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/283/neogenomics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference 2025-01-06T07:55:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/282/neogenomics-newly-published-study-underscores-potential-of-ctdna-as-a-predictive-tool-for-monitoring-patients-with-high-risk-melanoma 2024-12-11T08:05:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/281/neogenomics-to-present-key-research-on-hematologic-malignancies-at-the-2024-american-society-of-hematology-annual-meeting 2024-12-09T08:10:03-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/280/neogenomics-to-present-new-data-at-amp-2024-highlighting-the-impact-of-ctdna-and-ngs-for-advancing-cancer-diagnostics-and-personalized-treatment 2024-11-19T08:15:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/279/felicia-williams-joins-neogenomics-board-of-directors 2024-11-14T08:10:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/278/neogenomics-to-participate-in-the-piper-sandler-36th-annual-healthcare-conference 2024-11-08T07:00:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/277/neogenomics-reports-third-quarter-2024-results 2024-11-05T07:00:15-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/276/neogenomics-receives-new-york-state-approval-for-neo-comprehensive-solid-tumor-test 2024-10-22T08:10:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/275/neogenomics-to-report-third-quarter-2024-financial-results-on-nov-5-2024 2024-10-15T07:30:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/274/neogenomics-launches-aml-express-for-rapid-genetic-profiling-of-acute-myeloid-leukemia 2024-10-08T08:10:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/273/neogenomics-announces-new-radar-technology-and-resolution-of-radar-1-0-litigation 2024-09-23T18:47:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/272/neogenomics-to-present-new-data-at-esmo-2024-highlighting-the-value-of-ctdna-and-ngs-for-advancing-cancer-diagnostics-and-personalized-treatment 2024-09-11T08:05:19-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/271/neogenomics-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference 2024-08-29T08:37:05-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/270/neogenomics-reports-second-quarter-2024-results 2024-07-30T19:02:05-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/269/neogenomics-to-report-second-quarter-2024-financial-results-on-july-29-2024 2024-07-09T08:17:42-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/268/fort-myers-mayor-to-proclaim-june-as-neogenomics-commitment-to-cancer-month 2024-06-13T08:13:54-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/267/neogenomics-to-introduce-comprehensive-lung-solution-feature-hematopathology-services-at-asco-offering-actionable-insights-to-support-treatment-management 2024-05-28T14:26:38-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/266/neogenomics-reports-first-quarter-2024-results 2024-04-30T09:48:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/265/neogenomics-announces-senior-leadership-promotions 2024-04-18T08:08:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/264/neogenomics-to-report-first-quarter-2024-financial-results-on-april-30-2024 2024-04-09T08:20:18-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/263/neogenomics-showcases-commitment-to-transforming-cancer-patient-care-at-aacr-2024-annual-meeting 2024-03-27T08:56:23-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/262/neogenomics-releases-inaugural-environmental-social-and-governance-esg-report 2024-03-20T08:11:42-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/261/neogenomics-to-participate-in-the-td-cowen-44th-annual-health-care-conference 2024-03-01T08:24:22-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/260/neogenomics-reports-fourth-quarter-and-full-year-2023-results 2024-02-27T15:19:54-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/259/neogenomics-signs-working-with-cancer-pledge-in-support-of-employees 2024-02-01T08:18:56-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/258/neogenomics-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-20-2024 2024-02-01T08:18:56-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/257/neogenomics-to-participate-in-the-42nd-annual-j-p-morgan-healthcare-conference 2024-01-02T11:13:05-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/256/neogenomics-to-appeal-ruling 2024-01-02T11:13:05-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/255/neogenomics-to-present-new-data-at-san-antonio-breast-cancer-symposium-highlighting-utility-of-radar-for-therapy-response 2023-12-06T16:45:46-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/254/neogenomics-to-participate-at-the-piper-sandler-35th-annual-healthcare-conference 2023-11-14T10:11:31-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/253/neogenomics-reports-third-quarter-2023-results 2023-11-07T08:34:50-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/252/neogenomics-announces-the-commercial-availability-of-two-new-tests-expanding-its-next-generation-sequencing-and-lung-cancer-portfolios 2023-10-31T09:42:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/251/neogenomics-to-report-third-quarter-2023-financial-results-on-november-6-2023 2023-10-31T09:42:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/250/neogenomics-reports-second-quarter-2023-results 2023-08-28T09:43:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/249/neogenomics-announces-medicare-coverage-for-radar-assay-for-minimal-residual-disease-and-recurrence-in-breast-cancer 2023-10-31T09:42:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/248/neogenomics-to-report-second-quarter-2023-financial-results-on-august-8-2023 2023-08-03T15:16:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/247/neogenomics-expands-board-of-directors-with-appointments-of-three-independent-directors 2023-08-03T15:16:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/246/neogenomics-radar-assay-for-minimal-residual-disease-receives-first-commercial-coverage 2023-08-03T15:16:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/245/neogenomics-and-german-breast-group-announce-new-data-demonstrating-clinical-potential-of-the-radar-mrd-assay-in-hr-her2--breast-cancer 2023-08-03T15:16:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/244/neogenomics-to-participate-at-the-goldman-sachs-44th-annual-global-healthcare-conference 2023-08-03T15:16:45-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/243/neogenomics-to-showcase-the-transformational-impact-of-radarr-assay-for-molecular-residual-disease-and-recurrence-monitoring-at-asco 2023-08-03T15:16:45-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/242/neogenomics-reports-first-quarter-2023-results 2023-08-04T08:48:04-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/241/neogenomics-to-participate-at-the-bofa-securities-2023-healthcare-conference 2023-08-03T14:31:27-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/240/neogenomics-to-announce-first-quarter-2023-financial-results 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/239/neogenomics-to-participate-at-the-22nd-annual-needham-virtual-healthcare-conference 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/238/neogenomics-to-share-nine-abstracts-at-the-american-association-of-cancer-research-aacr-annual-meeting-2023 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/237/neogenomics-to-host-investor-day-on-april-4-2023 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/236/neogenomics-announces-commercial-availability-of-the-radarr-molecular-residual-disease-test 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/235/neogenomics-expands-ngs-portfolio-with-launch-of-neo-comprehensivetm---solid-tumor-cgp-and-neo-comprehensivetm---myeloid-disorders-cgp 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/234/neogenomics-to-present-at-the-44th-annual-raymond-james-institutional-investors-conference 2023-08-03T14:36:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/233/neogenomics-reports-fourth-quarter-and-full-year-2022-results 2023-08-03T14:36:53-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/232/neogenomics-schedules-its-fourth-quarter-and-full-year-2022-earnings-release-for-february-23-2023 2023-02-06T07:00:50-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/231/radar-assay-demonstrates-clinical-potential-for-helping-oncologists-determine-whether-or-not-muscle-invasive-bladder-cancer-patients-undergo-radical-surgery 2023-08-03T14:40:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/230/neogenomics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 2023-08-03T14:40:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/229/neogenomics-announces-chief-financial-officer-transition 2023-08-03T14:40:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/228/radarr-assay-demonstrates-clinical-potential-for-detecting-disease-recurrence-across-all-types-of-early-breast-cancer-including-triple-negative-disease 2023-08-03T14:40:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/227/neogenomics-and-immunogen-launch-new-program-giving-ovarian-cancer-patients-access-to-novel-fr-biomarker-testing-to-support-the-launch-of-elaheretm 2023-08-03T14:40:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/226/neogenomics-reports-third-quarter-2022-results 2023-08-03T14:40:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/225/neogenomics-appoints-david-perez-industry-veteran-and-former-terumo-bct-ceo-to-its-board-of-directors 2023-08-03T14:40:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/224/neogenomics-provides-update-on-moldx-submission-for-crc-and-radartm-commercial-launch 2023-08-03T14:40:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/223/neogenomics-schedules-its-third-quarter-2022-earnings-release-for-november-8-2022 2023-08-03T14:40:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/222/neogenomics-lab-operations-hurricane-ian-update 2022-10-03T17:04:39-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/221/neogenomics-hurricane-ian-emergency-response 2022-09-29T12:28:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/220/neogenomics-and-liquid-biopsy-subsidiary-inivata-and-collaborators-to-present-new-data-at-esmo-congress-2022 2023-08-03T14:40:54-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/219/neogenomics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 2023-08-03T14:40:54-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/218/neogenomics-reports-revenue-of-125-million-in-the-second-quarter 2023-08-03T14:40:55-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/217/neogenomics-announces-chief-executive-officer-appointment 2023-08-03T14:40:55-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/216/neogenomics-schedules-its-second-quarter-2022-earnings-release-for-august-9-2022 2022-07-15T16:06:16-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/215/neogenomics-liquid-biopsy-subsidiary-inivata-announces-new-data-demonstrating-clinical-potential-of-the-radartm-mrd-test-in-hr-her2--breast-cancer 2022-06-21T02:01:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/214/neogenomics-to-participate-in-multiple-upcoming-institutional-investor-conferences 2022-06-03T16:06:29-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/213/neogenomics-receives-cap-certification-in-their-suzhou-china-pharma-services-laboratory 2022-06-03T07:00:21-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/212/neogenomics-appoints-lynn-tetrault-interim-ceo 2022-05-16T07:01:16-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/211/neogenomics-liquid-biopsy-subsidiary-inivata-and-collaborators-present-new-data-further-validating-the-application-of-its-radarr-mrd-and-invisionfirstr-lung-tests-at-the-2022-asco-annual-meeting 2022-05-10T02:01:11-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/210/neogenomics-announces-leadership-transition-appointing-vishal-sikri-as-president-and-chief-commercial-officer-of-inivata-liquid-biopsy-subsidiary 2022-05-09T07:00:35-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/209/neogenomics-to-participate-in-the-bofa-securities-2022-healthcare-conference 2022-05-05T16:09:13-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/208/neogenomics-reports-revenue-of-117-million-in-the-first-quarter 2022-04-27T07:01:15-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/207/neogenomics-inc-announces-partnership-with-lilly-for-lung-cancer-sponsored-testing-program-utilizing-the-neotyper-dna-and-rna-assay 2022-04-25T07:00:35-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/206/neogenomics-announces-that-inivata-liquid-biopsy-subsidiary-and-collaborators-have-published-clinical-validation-data-for-radartm-assay-mrd-assay-at-aacr-2022 2022-04-11T10:00:42-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/205/neogenomics-inc-expands-its-global-strategic-partnership-initiatives-with-biognosys-ag-on-multiple-next-generation-proteomics-solutions-supporting-biopharma-rd 2022-04-11T07:00:51-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/204/neogenomics-schedules-its-first-quarter-2022-earnings-release-for-april-27-2022 2022-04-08T16:05:47-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/203/neogenomics-announces-ceo-departure-and-initiates-ceo-search 2022-03-28T16:09:18-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/202/neogenomics-announces-that-inivata-liquid-biopsy-subsidiary-and-collaborators-have-published-clinical-validation-data-for-radartm-assay-in-non-small-cell-lung-cancer 2022-03-17T03:00:16-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/201/neogenomics-to-participate-in-multiple-upcoming-institutional-investor-conferences 2022-03-02T16:10:30-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/200/neogenomics-reports-full-year-revenue-of-484-million-and-126-million-for-the-fourth-quarter-of-2021 2022-02-23T07:01:33-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/199/neogenomics-appoints-dr-shashi-kulkarni-a-world-renowned-oncology-genomics-expert-and-innovator-as-chief-scientific-officer 2022-02-14T07:01:00-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/198/neogenomics-liquid-biopsy-subsidiary-inivata-and-collaborators-publish-positive-results-from-prospective-clinical-study-of-radartm-in-head-and-neck-squamous-cell-carcinoma 2022-02-11T02:00:22-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/197/neogenomics-to-participate-virtually-in-multiple-upcoming-institutional-investor-conferences 2022-02-08T07:01:36-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/196/neogenomics-schedules-its-fourth-quarter-and-full-year-2021-earnings-release-for-february-23-2022 2022-02-02T16:07:35-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/195/neogenomics-first-to-partner-with-biomarker-collaborative-and-deliver-patient-resources-along-with-oncology-testing-results 2022-01-24T07:01:05-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/194/neogenomics-announces-radartm-assay-receives-ce-mark-and-is-submitted-for-us-reimbursement-via-the-moldx-program 2022-01-11T12:52:30-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/193/neogenomics-appoints-david-eberhard-md-phd-as-chief-medical-officer-of-inivata-liquid-biopsy-subsidiary 2021-12-13T02:00:20-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/192/neogenomics-to-leverage-thermo-fisher-scientifics-ion-torrent-genexus-system-in-upcoming-phase-1-study-for-myeloid-cancers 2021-12-10T07:00:34-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/191/neogenomics-to-participate-in-the-stephens-annual-investment-conference-2021 2021-11-30T07:01:17-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/190/neogenomics-appoints-dave-daly-to-its-board-of-directors 2021-11-10T07:01:14-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/189/neogenomics-reports-revenue-of-121-million-in-the-third-quarter 2021-11-04T07:02:59-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/188/neogenomics-announces-leadership-team-transition 2021-11-04T07:01:30-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/187/neogenomics-liquid-biopsy-subsidiary-inivata-announces-clinical-collaboration-with-princess-margaret-cancer-center-for-the-use-of-its-liquid-biopsy-assays 2021-10-19T02:00:40-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/186/neogenomics-schedules-its-third-quarter-2021-earnings-release-for-november-4-2021 2021-10-13T16:20:11-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/185/neogenomics-announces-board-of-directors-transition 2021-10-12T16:05:25-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/184/neogenomics-liquid-biopsy-subsidiary-inivata-and-collaborators-to-present-data-that-further-validate-the-application-of-its-radartm-mrd-and-invisionfirstr-lung-assays-at-the-esmo-congress-2021 2021-09-09T07:00:18-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/183/neogenomics-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference 2021-09-01T16:06:34-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/182/neogenomics-reports-40-revenue-growth-to-122-million-in-the-second-quarter 2021-08-06T07:00:32-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/181/neogenomics-schedules-its-second-quarter-2021-earnings-release-for-august-6-2021 2021-07-16T14:38:20-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/180/neogenomics-completes-inivata-acquisition---combining-best-in-class-liquid-biopsy-technology-with-leading-community-oncology-platform 2021-06-18T07:30:41-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/179/neogenomics-to-participate-virtually-in-multiple-upcoming-institutional-investor-conferences 2021-05-27T16:05:08-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/178/neogenomics-to-participate-in-the-bank-of-america-2021-health-care-conference 2021-05-10T16:15:23-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/177/neogenomics-reports-9-revenue-growth-to-116-million-in-the-first-quarter 2021-05-05T07:01:07-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/176/neogenomics-to-acquire-inivata---combining-best-in-class-liquid-biopsy-technology-with-leading-community-oncology-platform 2021-05-05T00:01:11-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/175/neogenomics-announces-the-launch-of-biomarker-assist-kras-single-gene-testing-sgt-program-for-advanced-or-metastatic-stage-iv-non-small-cell-lung-cancer-patients 2021-04-19T07:00:50-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/174/neogenomics-to-participate-in-the-20th-annual-needham-virtual-healthcare-conference 2021-04-13T07:00:53-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/173/neogenomics-schedules-its-first-quarter-2021-earnings-release-for-may-5-2021 2021-04-07T16:07:09-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/172/neogenomics-agrees-to-acquire-trapelo-health 2021-03-24T07:00:55-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/171/neogenomics-and-elevation-oncology-announce-collaboration-to-expand-genomic-testing-for-nrg1-fusions-across-solid-tumors-in-support-of-the-phase-2-crestone-study 2021-03-16T07:01:24-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/170/neogenomics-to-participate-in-the-virtual-raymond-james-42nd-annual-institutional-investors-conference 2021-03-01T07:01:07-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/169/neogenomics-to-participate-in-the-virtual-10th-annual-svb-leerink-global-healthcare-conference 2021-02-25T07:00:58-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/168/neogenomics-reports-18-revenue-growth-to-126-million-in-the-fourth-quarter 2021-02-24T07:01:42-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/167/neogenomics-announces-ceo-succession 2021-02-24T07:00:48-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/166/neogenomics-to-participate-in-the-btig-virtual-medtech-digital-health-life-science-diagnostic-tools-conference 2021-02-16T07:00:36-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/165/neogenomics-schedules-its-fourth-quarter-and-full-year-2020-earnings-release-for-february-24-2021 2021-02-05T07:00:32-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/164/parexel-and-neogenomics-announce-strategic-collaboration-in-precision-medicine-to-improve-study-designs-and-accelerate-patient-matching-in-oncology-clinical-trials 2021-02-04T07:00:34-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/163/neogenomics-and-tempus-join-the-access-to-comprehensive-genomic-profiling-coalition 2021-02-02T08:59:03-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/162/neogenomics-announces-pricing-of-public-offerings-of-common-stock-and-convertible-senior-notes 2021-01-06T23:00:47-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/161/neogenomics-announces-proposed-public-offerings-of-common-stock-and-convertible-senior-notes 2021-01-05T16:07:39-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/160/neogenomics-to-virtually-participate-in-the-39th-annual-j-p-morgan-healthcare-conference 2021-01-04T07:31:40-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/159/neogenomics-to-virtually-participate-in-fireside-chat-at-the-stephens-annual-investment-conference-2020 2020-11-13T16:05:56-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/158/neogenomics-to-offer-mobile-phlebotomy-services-for-liquid-biopsy-tests 2020-11-09T10:49:32-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/157/neogenomics-reports-revenue-growth-of-20-to-record-125-million-in-the-third-quarter 2020-10-27T07:01:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/156/neogenomics-announces-plans-to-expand-global-footprint-in-pharma-services-by-opening-clinical-research-laboratory-in-suzhou-china 2020-10-13T09:01:38-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/155/neogenomics-schedules-its-third-quarter-earnings-release-for-october-27-2020 2020-10-01T07:00:26-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/154/neogenomics-to-virtually-participate-in-fireside-chat-at-the-18th-annual-morgan-stanley-global-healthcare-conference 2020-09-11T08:57:55-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/153/neogenomics-reports-revenue-of-87-million-in-the-second-quarter-amid-covid-19-pandemic 2020-07-28T07:01:23-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/152/neogenomics-announces-board-appointments 2020-07-20T07:00:57-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/151/neogenomics-schedules-its-second-quarter-earnings-release-for-july-28-2020 2020-07-06T09:14:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/150/neogenomics-launches-comprehensive-suite-of-solid-tumor-liquid-biopsy-tests-for-cancer-patients 2020-06-29T07:01:13-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/149/neogenomics-to-virtually-present-at-the-raymond-james-human-health-innovation-conference 2020-06-02T17:26:33-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/148/neogenomics-to-virtually-participate-in-fireside-chat-at-the-40th-annual-william-blair-growth-stock-conference 2020-06-01T16:08:08-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/147/neogenomics-to-virtually-participate-in-17th-annual-craig-hallum-institutional-investor-conference 2020-05-26T07:20:56-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/146/neogenomics-enters-strategic-collaboration-with-inivata-to-commercialize-invisionfirstr-lung-liquid-biopsy-test 2020-05-26T05:00:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/145/neogenomics-to-virtually-participate-in-fireside-chat-at-bofa-securities-2020-health-care-conference 2020-05-11T16:07:16-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/144/neogenomics-and-bayer-collaborate-to-offer-ntrk-testing-for-certain-colorectal-and-thyroid-cancer-patients 2020-05-05T08:01:10-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/143/neogenomics-announces-pricing-of-public-offerings-of-common-stock-and-convertible-senior-notes 2020-04-30T06:00:27-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/142/neogenomics-announces-proposed-public-offerings-of-common-stock-and-convertible-senior-notes 2020-04-29T17:20:10-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/141/neogenomics-reports-11-revenue-growth-to-106-million-in-the-first-quarter 2020-04-28T07:00:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/140/neogenomics-provides-covid-19-business-update 2020-04-09T07:00:21-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/139/neogenomics-integrates-halor-from-indica-labs 2020-04-03T07:00:15-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/138/neogenomics-schedules-its-first-quarter-earnings-release-for-april-28-2020 2020-04-01T07:00:43-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/137/neogenomics-announces-three-year-contract-to-be-cornerstone-oncology-and-cancer-testing-laboratory-for-large-national-group-purchasing-organization 2020-03-02T07:00:44-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/136/neogenomics-to-present-at-41st-annual-raymond-james-institutional-investor-conference 2020-02-28T07:00:48-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/135/neogenomics-reports-40-revenue-growth-to-107-million-in-the-fourth-quarter 2020-02-27T07:09:09-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/134/neogenomics-schedules-its-fourth-quarter-and-fiscal-year-2019-earnings-release-for-february-27-2020 2020-02-06T07:00:38-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/133/neogenomics-announces-leadership-appointments 2020-02-05T07:00:35-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/132/neogenomics-acquires-oncology-division-from-human-longevity-for-37-million 2020-01-10T08:41:45-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/131/neogenomics-to-participate-in-fireside-chat-at-stephens-21st-annual-investment-conference 2019-11-06T16:05:56-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/130/neogenomics-reports-51-revenue-growth-to-105-million-in-the-third-quarter 2019-11-04T11:10:22-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/129/neogenomics-schedules-its-third-quarter-earnings-release-for-october-29-2019 2019-10-01T16:08:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/128/neogenomics-to-present-at-2019-cantor-global-healthcare-conference 2019-09-25T16:06:38-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/127/neogenomics-to-participate-in-two-upcoming-september-institutional-investor-conferences 2019-09-03T16:15:38-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/126/neogenomics-announces-leadership-transition-and-reiterates-recently-increased-2019-financial-guidance 2019-08-08T10:02:12-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/125/neogenomics-announces-grand-opening-of-new-pharma-services-laboratory-in-singapore 2019-07-31T07:00:29-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/124/neogenomics-reports-50-revenue-growth-to-record-102-million-in-the-second-quarter 2019-07-30T07:02:10-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/123/neogenomics-to-build-state-of-the-art-oncology-laboratory-and-global-headquarters-in-fort-myers-florida 2019-07-09T07:01:45-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/122/neogenomics-schedules-its-second-quarter-earnings-release-for-july-30-2019 2019-07-01T16:01:16-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/121/neogenomics-announces-new-250-million-credit-agreement 2019-06-27T16:01:22-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/120/neogenomics-to-present-at-39th-annual-william-blair-growth-stock-conference 2019-05-30T16:07:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/119/neogenomics-and-qiagen-collaborate-to-offer-companion-diagnostic-test-for-hr-her2---advanced-breast-cancer-patients-to-detect-a-pik3ca-mutation 2019-05-28T06:01:13-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/118/neogenomics-to-attend-the-16th-annual-craig-hallum-institutional-investor-conference 2019-05-23T16:30:59-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/117/neogenomics-announces-pricing-on-public-offering-of-common-stock 2019-05-21T20:11:15-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/116/neogenomics-announces-proposed-public-offering-of-common-stock 2019-05-20T16:11:48-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/115/neogenomics-reports-51-revenue-growth-to-record-96-million-in-the-first-quarter 2019-05-01T08:42:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/114/neogenomics-schedules-its-first-quarter-earnings-release-for-april-30-2019 2019-04-03T16:39:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/113/neogenomics-to-present-at-18th-annual-needham-company-health-care-conference 2019-04-02T17:20:57-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/112/neogenomics-launches-immuno-oncology-companion-diagnostic-test-for-triple-negative-breast-cancer-in-conjunction-with-fda-approval-for-tecentriqr 2019-03-11T07:01:04-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/111/neogenomics-to-present-at-39th-annual-cowen-and-company-health-care-conference 2019-03-07T16:51:35-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/110/neogenomics-reports-record-revenue-of-76-million-with-17-organic-revenue-growth-in-the-fourth-quarter 2019-02-19T07:00:32-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/109/neogenomics-schedules-its-fourth-quarter-and-fiscal-year-2018-earnings-release-for-february-19-2019 2019-01-28T07:00:04-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/108/neogenomics-appoints-dr-lawrence-m-weiss-as-chief-scientific-officer 2018-12-13T07:00:10-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/107/neogenomics-announces-pricing-on-secondary-offering-of-common-stock-by-selling-stockholder 2018-12-12T07:34:51-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/106/neogenomics-announces-secondary-offering-of-common-stock-by-selling-stockholder 2018-12-11T16:10:04-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/105/neogenomics-completes-acquisition-of-genoptix-inc 2018-12-10T09:10:04-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/104/qiagen-and-neogenomics-collaborate-to-offer-cancer-patients-day-one-access-to-innovative-companion-diagnostics-for-newly-approved-drugs 2018-11-30T17:01:28-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/103/neogenomics-reports-17-revenue-growth-to-record-69-million 2018-10-30T07:00:16-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/102/neogenomics-signs-definitive-agreement-to-acquire-genoptix 2018-10-23T07:00:23-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/101/neogenomics-schedules-its-third-quarter-earnings-release-for-october-30-2018 2018-10-01T07:00:11-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/100/neogenomics-announces-participation-in-nci-match-clinical-trial 2018-09-24T07:00:07-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/99/neogenomics-awarded-clinical-reference-laboratory-testing-services-agreement-with-premier 2018-09-12T08:13:42-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/98/neogenomics-announces-pricing-on-public-offering-of-common-stock 2018-08-09T20:40:38-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/97/neogenomics-announces-proposed-public-offering-of-common-stock 2018-08-06T16:19:07-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/96/neogenomics-reports-record-revenue-of-67-7-million-with-14-increase-in-clinical-volume-growth-and-95-increase-in-pharma-services-backlog 2018-07-24T07:00:15-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/95/neogenomics-schedules-its-second-quarter-earnings-release-for-july-24-2018 2018-07-02T16:05:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/94/neogenomics-redeems-100-of-series-a-redeemable-preferred-stock 2018-06-25T16:05:05-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/93/ppd-and-neogenomics-forming-global-strategic-alliance-for-pathology-and-molecular-testing-solutions 2018-06-01T08:02:25-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/92/neogenomics-to-participate-in-two-upcoming-investor-conferences 2018-05-25T16:05:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/91/neogenomics-reports-revenue-of-63-4-million-net-income-of-0-6-million-and-adjusted-ebitda-of-9-2-million-in-the-first-quarter-of-2018 2018-05-01T07:00:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/90/neogenomics-schedules-its-first-quarter-earnings-release-for-may-1-2018 2018-04-02T17:00:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/89/neogenomics-announces-executive-appointments 2018-03-20T07:00:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/88/neogenomics-reports-revenue-of-67-8-million-on-18-7-clinical-volume-growth-and-10-5-million-of-adjusted-ebitda-in-the-fourth-quarter-of-2017 2018-02-21T07:02:23-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/87/neogenomics-schedules-its-fourth-quarter-and-fiscal-year-2017-earnings-release-for-february-21-2018 2018-01-30T07:00:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/86/neogenomics-announces-six-clinical-data-presentations-to-be-made-at-the-american-society-of-hematology-meeting 2017-12-06T07:00:02-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/85/neogenomics-joins-thermo-fisher-scientifics-companion-diagnostic-center-of-excellence-program-with-the-launch-of-oncomine-dx-target-test 2017-12-05T07:00:00-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/84/neogenomics-europe-s-a-opens-its-doors-in-rolle-switzerland-laboratory-hosting-business-leaders-dignitaries-and-local-government-officials 2017-11-09T07:00:01-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/83/neogenomics-reports-revenue-of-63-1-million-on-17-volume-growth-and-11-reduction-in-average-cost-per-test-in-the-third-quarter-of-2017 2017-10-25T07:00:11-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/82/neogenomics-announces-the-opening-of-its-first-international-laboratory-near-geneva-switzerland-to-support-clinical-trials 2017-10-24T09:00:09-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/81/neogenomics-announces-preliminary-quarter-3-results-financial-impacts-of-hurricanes-and-summary-quarter-4-guidance 2017-10-12T16:01:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/80/neogenomics-schedules-its-q3-2017-earnings-release-for-october-25-2017 2017-09-28T07:00:05-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/79/neogenomics-reports-on-impacts-from-hurricane-irma 2017-09-11T15:04:10-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/78/neogenomics-reports-record-revenue-of-66-1-million-on-16-volume-growth-and-13-reduction-in-average-cost-per-test-in-the-second-quarter-of-2017 2017-07-25T07:00:04-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/77/neogenomics-schedules-its-q2-2017-earnings-release-for-july-25-2017 2017-06-28T07:00:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/76/neogenomics-announces-expansion-of-immuno-oncology-profiling-tests 2017-06-02T07:00:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/75/neogenomics-reports-that-its-neolab-liquid-biopsy-prostate-test-is-more-accurate-than-conventional-biopsies-in-predicting-high-grade-prostate-cancer 2018-07-25T15:02:45-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/74/neogenomics-reports-15-volume-growth-and-10-reduction-in-average-cost-per-test-in-the-first-quarter-of-2017 2017-04-26T07:00:07-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/73/neogenomics-appoints-bill-bonello-as-vice-president-treasurer-and-director-of-corporate-development 2017-04-20T07:00:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/72/neogenomics-schedules-its-q1-2017-earnings-release-for-april-26-2017 2017-04-14T16:01:33-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/71/neogenomics-and-definiens-enter-into-agreement-to-develop-novel-assays-for-clinical-trials-clinical-testing 2017-03-13T07:00:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/70/neogenomics-reports-122-revenue-growth-to-60-5-million-and-11-reduction-in-average-cost-per-test-in-the-fourth-quarter-of-2016 2017-02-22T07:00:04-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/69/neogenomics-schedules-its-q4-and-full-year-2016-earnings-release-for-february-22-2017 2017-02-08T11:22:27-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/68/neogenomics-closes-150-million-senior-credit-facility 2016-12-22T09:51:31-05:00 https://ir.neogenomics.com/news-events/press-releases/detail/67/neogenomics-reports-142-revenue-growth-to-60-8-million-and-a-record-9-6-million-in-cash-flow-from-operations-in-the-third-quarter-of-2016 2016-10-26T07:00:12-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/66/neogenomics-schedules-its-q3-2016-earnings-release-for-october-26-2016 2016-10-11T07:00:12-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/65/neogenomics-reports-159-revenue-growth-to-63-1-million-and-strong-gains-in-profitability-in-the-second-quarter-of-2016 2016-10-03T13:10:04-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/64/neogenomics-schedules-its-q2-2016-earnings-release-for-july-26-2016 2016-10-03T13:10:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/63/neogenomics-reports-159-revenue-growth-to-59-7-million-and-442-adjusted-ebitda-increase-to-8-2-million-driven-by-clarient-acquisition-and-strong-volume-gains 2016-10-03T13:10:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/62/neogenomics-schedules-its-q1-2016-earnings-release-for-april-27-2016 2016-10-03T13:10:01-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/61/neogenomics-reports-record-revenue-of-27-2-million-and-record-adjusted-ebitda-of-2-9-million-in-fourth-quarter-driven-by-strong-volume-gains 2016-10-03T13:10:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/60/neogenomics-schedules-its-q4-2015-and-full-year-2015-earnings-release-for-march-1-2016 2018-07-25T15:03:00-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/59/neogenomics-completes-acquisition-of-clarient-inc 2016-10-03T13:09:58-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/58/neogenomics-launches-new-liquid-biopsy-tests-for-monitoring-solid-tumors-and-predicting-resistance-to-btk-inhibitors 2018-07-25T15:01:56-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/57/neogenomics-reports-revenue-of-25-1-million-and-record-adjusted-ebitda-of-2-8-million-driven-by-a-25-increase-in-test-volume-in-the-third-quarter-of-2015 2016-10-03T13:09:56-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/56/neogenomics-amends-strategic-alliance-agreement-with-covance-central-laboratory-services 2016-10-03T13:09:55-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/55/neogenomics-signs-definitive-agreement-to-acquire-clarient-inc 2018-07-25T15:02:09-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/54/neogenomics-schedules-its-q3-2015-earnings-release-for-october-29-2015 2016-10-03T13:09:54-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/53/neogenomics-launches-new-neosite-cervical-fish-assay-for-evaluation-of-abnormal-pap-tests 2018-07-25T15:02:25-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/52/neogenomics-enters-into-national-agreement-with-premier-inc-to-offer-cancer-genetics-testing-services-to-3600-hospitals 2016-10-03T13:09:52-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/51/neogenomics-reports-18-revenue-growth-and-strong-gains-in-adjusted-ebitda 2016-10-03T13:09:51-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/50/neogenomics-expands-multimodality-cancer-profile-testing 2016-10-03T13:09:50-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/49/neogenomics-launches-germline-cancer-predisposition-testing 2016-10-03T13:09:49-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/48/neogenomics-schedules-its-q2-2015-earnings-release-for-july-23-2015 2016-10-03T13:09:48-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/47/neogenomics-announces-new-directors 2016-10-03T13:09:47-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/46/neogenomics-set-to-join-russell-3000-index 2016-10-03T13:09:47-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/45/neogenomics-launches-twelve-neolab-liquid-biopsy-tests-for-hematologic-diseases 2016-10-03T13:09:46-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/44/neogenomics-reports-27-revenue-growth-driven-by-strong-volume-gains-and-pathlogic-acquisition 2016-10-03T13:09:44-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/43/neogenomics-announces-promotions 2016-10-03T13:09:43-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/42/neogenomics-schedules-its-q1-2015-earnings-release-for-april-28-2015 2016-10-03T13:09:42-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/41/neogenomics-reports-record-revenue-of-25-0-million-adjusted-ebitda-of-2-8-mm-and-net-income-of-0-02-per-share-for-the-fourth-quarter-2014 2016-10-03T13:09:41-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/40/neogenomics-schedules-its-q4-2014-and-full-year-2014-earnings-release-for-february-24-2015 2016-10-03T13:09:40-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/39/neogenomics-raises-revenue-guidance-to-25-million-and-eps-guidance-to-0-01---0-02-per-share-for-quarter-4-2014 2016-10-03T13:09:40-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/38/neogenomics-the-robert-h-lurie-comprehensive-cancer-center-of-northwestern-university-and-the-northwestern-medicine-developmental-therapeutics-institute-launch-collaborative-translational-research-program 2016-10-03T13:09:39-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/37/neogenomics-reports-38-increase-in-revenue-to-a-record-23-2-million-and-adjusted-ebitda-of-2-6-million-for-the-third-quarter-of-2014 2016-10-03T13:09:38-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/36/neogenomics-is-first-to-offer-molecular-testing-for-resistance-to-bruton-tyrosin-kinase-inhibitors-for-chronic-lymphocytic-leukemia 2016-10-03T13:09:37-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/35/neogenomics-launches-315-gene-next-generation-sequencing-test-for-solid-tumor-discovery-profiling 2016-10-03T13:09:36-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/33/neogenomics-appoints-robert-j-shovlin-as-chief-operating-officer 2016-10-03T13:09:34-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/34/neogenomics-schedules-its-q3-2014-earnings-release-for-october-30-2014 2016-10-03T13:09:35-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/32/neogenomics-announces-closing-of-recent-equity-offering-and-exercise-in-full-of-underwriters-over-allotment-option 2016-10-03T13:09:34-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/30/neogenomics-announces-pricing-of-32-2-million-public-offering 2016-10-03T13:09:32-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/31/neogenomics-announces-public-offering-of-common-stock 2016-10-03T13:09:33-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/28/neogenomics-reports-record-revenues-of-20-7-million-on-40-test-volume-growth-and-expanding-gross-margins-for-the-second-quarter-2014 2016-10-03T13:09:30-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/27/neogenomics-expands-next-generation-sequencing-services-and-offers-23-different-profiles-for-various-hematologic-and-solid-cancers 2016-10-03T13:09:29-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/29/neogenomics-completes-acquisition-of-path-logic 2016-10-03T13:09:30-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/25/neogenomics-raises-guidance-and-projects-30-year-over-year-revenue-growth-in-quarter-2-2014 2016-10-03T13:09:27-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/26/neogenomics-schedules-its-q2-2014-earnings-release-for-july-17-2014 2016-10-03T13:09:27-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/24/neogenomics-selected-by-aurora-diagnostics-as-primary-partner-for-molecular-fish-and-immunohistochemistry-testing 2016-10-03T13:09:26-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/23/neogenomics-reports-revenue-of-18-2-million-and-adjusted-ebitda-of-1-7-million-for-the-first-quarter 2016-10-03T13:09:25-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/22/neogenomics-schedules-its-q1-2014-earnings-release-for-april-23-2014 2016-10-03T13:09:24-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/21/neogenomics-announces-next-generation-sequencing-tests-for-solid-tumor-cancers-and-myelodysplastic-syndrome 2016-10-03T13:09:23-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/20/neogenomics-reports-record-revenue-of-18-3-million-adjusted-ebitda-of-2-7-million-and-net-income-of-0-02-per-share-for-the-fourth-quarter-2013 2016-10-03T13:09:22-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/19/neogenomics-launches-22-new-cancer-genomic-tests-designed-for-actionable-profiling-of-various-hematologic-and-solid-cancers 2016-10-03T13:09:21-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/17/neogenomics-schedules-its-q4-2013-and-full-year-2013-earnings-release-for-february-19-2014 2016-10-03T13:09:20-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/18/neogenomics-is-the-first-laboratory-to-offer-calreticulin-calr-mutation-testing-for-the-diagnosis-and-classification-of-myeloproliferative-neoplasms 2016-10-03T13:09:21-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/16/neogenomics-reports-record-revenue-of-16-9-million-adjusted-ebitda-of-2-2-million-and-net-income-of-900k-for-the-third-quarter-2013 2016-10-03T13:09:18-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/15/neogenomics-schedules-its-q3-2013-earnings-release-for-october-23-2013 2016-10-03T13:09:17-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/14/neogenomics-revises-upward-its-quarter-3-2013-guidance 2016-10-03T13:09:17-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/5/neogenomics-reports-revenue-of-15-6-million-adjusted-ebitda-of-1-8-million-and-earnings-per-share-of-0-01-for-the-second-quarter-2013 2016-10-03T13:09:02-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/6/neogenomics-introduces-comprehensive-myelodysplastic-syndrome-mds-molecular-testing 2016-10-03T13:09:03-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/7/neogenomics-schedules-its-q2-2013-earnings-release-for-july-31-2013 2016-10-03T13:09:04-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/10/neogenomics-reports-record-quarterly-revenue-of-15-7-million-adjusted-ebitda-of-1-8-million-and-46-3-gross-margin-for-the-first-quarter 2016-10-03T13:09:09-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/9/neogenomics-schedules-its-q1-2013-earnings-release-for-april-25-2013 2016-10-03T13:09:08-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/12/neogenomics-announces-pricing-of-9-5-million-public-offering 2016-10-03T13:09:13-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/11/neogenomics-reports-181-increase-in-adjusted-ebitda-on-38-revenue-growth-and-achieves-profitability-in-2012 2016-10-03T13:09:12-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/13/neogenomics-schedules-its-q4-and-full-year-2012-earnings-release-for-february-14-2013 2016-10-03T13:09:14-04:00 https://ir.neogenomics.com/news-events/press-releases/detail/8/neogenomics-validates-and-launches-neosite-barretts-esophagus-fish-test-for-surveillance-and-diagnosis-of-high-grade-dysplasiaesophageal-cancer 2016-10-03T13:09:05-04:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20260310-leerink-global-healthcare-conference 2026-03-10T15:00:15-04:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20260303-td-cowen-46th-annual-health-care-conference 2026-02-18T07:25:46-05:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20260217-fourth-quarter-2025-financial-results-conference-call 2026-01-27T07:13:05-05:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20260113-44th-annual-j-p-morgan-healthcare-conference 2026-01-13T20:09:16-05:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20251209-2025-san-antonio-breast-cancer-symposium-sabcs 2025-12-10T07:17:50-05:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20251202-piper-sandler-37th-annual-healthcare-conference 2025-11-06T07:42:40-05:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20251119-stephens-annual-investment-conference 2025-11-06T07:40:09-05:00 https://ir.neogenomics.com/news-events/ir-calendar/detail/20251028-third-quarter-2025-financial-results-conference-call 2025-10-07T07:08:30-04:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-023691/wk-form4_1775248747.html 2026-04-03T16:39:55-04:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-023689/wk-form4_1775248724.html 2026-04-03T16:39:25-04:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0000102909-26-001879/primary_doc.html 2026-03-27T10:52:58-04:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-014150/wk-form4_1772579799.html 2026-03-03T18:17:10-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-014149/wk-form4_1772579782.html 2026-03-03T18:17:00-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-014147/wk-form4_1772579762.html 2026-03-03T18:16:39-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-014146/wk-form4_1772579744.html 2026-03-03T18:16:24-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-013315/wk-form3_1772488979.html 2026-03-02T17:03:34-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-011102/wk-form4_1771967722.html 2026-02-24T16:17:09-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-011099/wk-form4_1771967703.html 2026-02-24T16:16:45-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-011097/wk-form4_1771967680.html 2026-02-24T16:16:29-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-011095/wk-form4_1771967656.html 2026-02-24T16:16:22-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001077183-26-000010/neo-20251231.htm 2026-02-17T16:21:09-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001077183-26-000004/neo-20260217.htm 2026-02-17T07:07:58-05:00 https://ir.neogenomics.com/sec-filings/all-sec-filings/content/0001628280-26-002970/wk-form4_1769047301.html 2026-01-21T21:02:24-05:00 https://ir.neogenomics.com/disclaimer https://ir.neogenomics.com/sitemap https://ir.neogenomics.com/accessibility-statement